retatrutide clinical trial results 2024 2025 press release produces up to 30.3% weight loss in Phase 3 Retatrutide—A Game Changer in Obesity

Research Peptide FAQs Frequently Asked Questions Are there customs duties within Europe

Unlocking Sustainable Weight Loss with GLP1 Medications and Peptides at Illume Med Spa & Wellness Apr 18, 2025 2 min read In the evolving landscape of weight management, GLP-1 receptor agonists and peptides have emerged as transformative tools

Unique positioning: No other available peptide combines all three receptor targets

requires clinical setting, higher cost, time-intensive

The drugs are now known to demonstrate potent benefits for the cardiovascular, renal, and hepatic systems, with notable effects that are partly independent of their simultaneous effects on weight loss and type 2 diabetes

Some peptides and amino acids trigger the release of GLP-1 in the intestines